Live Breaking News & Updates on Ppamerican Academy Of Allergy
Stay updated with breaking news from Ppamerican academy of allergy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
email article Peanut sublingual immunotherapy (SLIT) was associated with significant desensitization in toddlers, ages 1 to 4 years, with no safety issues, a randomized trial showed. During the placebo-controlled trial, cumulative tolerated dose in the peanut SLIT group increased to 4,333 mg of peanut protein versus 143 mg in the placebo group ( P 0.0001), according to Edwin Kim, MD, of the University of North Carolina Food Allergy Initiative in Chapel Hill. The treatment effect achieved with peanut SLIT was stronger than that previously reported in studies involving older children and it tended to last longer, Kim said during his presentation at the American Academy of Allergy, Asthma & Immunology virtual meeting. ....